Trials / Completed
CompletedNCT04826549
A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Rose Research Center, LLC · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- —
Summary
The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy of the iCOquit Smokerlyzer could establish an additional, less expensive, reliable method for determining smoking status in tobacco research. Additionally, the portability of the device would allow for remote biochemical verification of smoking status, thus enlarging the number of participants that can be included in intervention studies.
Conditions
Timeline
- Start date
- 2021-03-22
- Primary completion
- 2021-10-27
- Completion
- 2021-10-27
- First posted
- 2021-04-01
- Last updated
- 2022-01-13
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04826549. Inclusion in this directory is not an endorsement.